Search Results

240 results for ptie

The 2025 Millionaire’s Club: 3 Quantum Computing Stocks to Buy Now

These three quantum computing stocks to buy represent diversified companies at the forefront of the quantum computing industry.

3 Auto Stocks to Buy Now: May 2024

Ensure a lucrative 2024 with the best auto stocks by discovering these companies’ strategic initiatives and business plans.

7 Tech Stocks That Also Provide Passive Income

$1,000 Goes a Long Way: 3 Stocks That Could Deliver Hefty Returns

Finding the right high-potential stocks to buy can be achieved with just a $1,000 investment to secure a comfortable retirement.

The Forever Dividend Portfolio: 3 A-Rated Stocks to Buy and Hold

These dividend stocks offer stable and consistent payouts, making them ideal for long-term investors seeking reliable income streams.

From Pennies to Profits: 3 Low-Priced Stocks With Sky-High Potential

Be Careful if You Own These Sectors

Earnings Growth Hamper Pain Therapeutics (PTIE) Rating

The current recommendation of Hold for Pain Therapeutics Inc (NASDAQ:PTIE) is derived using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier’s investing approach.…

The Nvidia Rivals: 3 AI Stocks Ready to Steal the Spotlight

Discover three AI stocks to buy now, as they gear up to steal the spotlight from Nvidia in the rest of 2024.

3 Cryptos to Stay Far, Far Away From: BONK, CAKE, AMP

While not all cryptocurrencies are equally risky, these are three cryptos to avoid as the SEC and CFTC crack down on exchanges this year.

Pain Therapeutics Jumps 50% on Promising Remoxy Study (PTIE)

Pain Therapeutics (PTIE) stock is soaring Tuesday after its REMOXY study shows the drug could deter prescription painkiller abuse.

7 Stocks to Buy if the Market Ends Up Plunging

Remoxy’s Rejection Drives PTIE Stock 70% Lower

The FDA Advisory Committee’s decision to vote against Remoxy has left PTIE stock in the dumps because the firm has very few other options coming…

Offload These Overdue Stocks: 3 to Purge From Your Portfolio ASAP

Offload three stocks to sell now to optimize your portfolio: PTON, with consistent losses; MSTR, tied to Bitcoin; and WING, facing high P/E.

3 Stocks to Watch on Monday: Twitter Inc (TWTR), Walt Disney Co (DIS) and Pain Therapeutics, Inc. (PTIE)

Twitter (TWTR) gets a downgrade amid buyout rumors, Disney (DIS) is lowered too and Pain Therapeutics (PTIE) suffers a huge setback.

Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling

Cannabis stocks are among the big movers investors are watching closely as a key piece of legislation is pushed forward for this sector.

PFIE Stock Earnings: Profire Energy Meets EPS, Beats Revenue for Q1 2024

PFIE stock results show that Profire Energy met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Biotech Movers: Enzo Biochem Rockets on Patent Ruling

ENZ is awarded $48.6 million in penalties, and more could be coming. Plus: Why Abiomed, Pain Therapeutics, Impax and BioCryst all took big falls.

3 Politicians Betting on a Stock Market Crash in 2024 

Want to become a millionaire just like your congressmen? Then just keep an eye on the politicians betting on stock market crash outcomes.

3 Reasons Why Nvidia Stock Will Finally Hit $1000/share

Market volatility seems unable to stop chipmaker Nvidia’s meteoric rally, as secular tail winds guide Nvidia stock higher.

Pain Therapeutics Stock Skyrockets on Alzheimer’s Grant

Pain Therapeutics (PTIE) stock was soaring Wednesday on news of a grant to study Alzheimer’s disease from the National Institutes of Health.

3 Pharmaceuticals Stocks to Sell Now

The overall ratings of 3 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong…

6 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…

6 Pharmaceutical Stocks to Sell Now

For the current week, the overall ratings of six Pharmaceutical stocks are worse, according to the Portfolio Grader database. Each of these rates a “D”…

8 – 10 of 240 results